📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Rome Therapeutics

1.1 - Company Overview

Rome Therapeutics Logo

Rome Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel therapies for cancer and autoimmune diseases harnessing the repeatome, including development of LINE-1 reverse transcriptase inhibitors for autoimmune diseases, supported by a data science platform that identifies active elements in the dark genome and assesses their roles in disease to guide drug development.

Products and services

  • Data Science Platform: Computational system that identifies active elements within the dark genome and assesses their roles in disease for drug development
  • LINE-1 RT Inhibitors: Enzyme-targeted program developing inhibitors targeting LINE-1 reverse transcriptase for the treatment of autoimmune diseases, with emphasis on LINE-1 RT inhibition
  • Repeatome-Guided Therapeutics: Repeatome-guided programs developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Rome Therapeutics

Pairwise Logo

Pairwise

HQ: United States Website
  • Description: Provider of plant-based innovation via the Fulcrum platform to accelerate production systems, developing seedless blackberries, black raspberries, red raspberries, and pitless cherries with year-round availability, and offering the Good Food for All program to expand access to fruits and vegetables.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pairwise company profile →
Seer Logo

Seer

HQ: United States Website
  • Description: Provider of proteomics tools and solutions, including the Proteograph Product Suite (integrated workflow with instruments, consumables, and software for deep, large-scale proteome analysis); Proteograph Analysis Suite for LC-MS data processing, analysis, and visualization; SP100 Automation Instrument; Proteograph Assay Kit; and Seer Technology Access Center services for proteomics research support.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Seer company profile →
MIDI Logo

MIDI

HQ: United States Website
  • Description: Provider of chemical analysis and microbial identification solutions for agriculture and environmental microbiology laboratories.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MIDI company profile →
HomeDNA Logo

HomeDNA

HQ: United States Website
  • Description: Provider of a home paternity test kit; a pharmaceutical firm.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full HomeDNA company profile →
Verinata Health Logo

Verinata Health

HQ: United States Website
  • Description: Provider of non-invasive tests for early identification of fetal chromosomal abnormalities, using proprietary technologies to enhance maternal and fetal health and reduce anxiety associated with the current multi-step process and false positives.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Verinata Health company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Rome Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Rome Therapeutics

2.2 - Growth funds investing in similar companies to Rome Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Rome Therapeutics

4.2 - Public trading comparable groups for Rome Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Rome Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Rome Therapeutics

What does Rome Therapeutics do?

Rome Therapeutics is a provider of novel therapies for cancer and autoimmune diseases harnessing the repeatome, including development of LINE-1 reverse transcriptase inhibitors for autoimmune diseases, supported by a data science platform that identifies active elements in the dark genome and assesses their roles in disease to guide drug development.

Who are Rome Therapeutics's competitors?

Rome Therapeutics's competitors and similar companies include Pairwise, Seer, MIDI, HomeDNA, and Verinata Health.

Where is Rome Therapeutics headquartered?

Rome Therapeutics is headquartered in United States.

How many employees does Rome Therapeutics have?

Rome Therapeutics has 1,000 employees 🔒.

When was Rome Therapeutics founded?

Rome Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Rome Therapeutics in?

Rome Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Rome Therapeutics

Who are the top strategic acquirers in Rome Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Rome Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Rome Therapeutics?

Top strategic M&A buyers groups and sectors for Rome Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Rome Therapeutics's sector and industry vertical

Which are the top PE firms investing in Rome Therapeutics's sector and industry vertical?

Top PE firms investing in Rome Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Rome Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Rome Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Rome Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Rome Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Rome Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Rome Therapeutics?

The key public trading comparables and valuation benchmarks for Rome Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Rome Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Rome Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Rome Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Rome Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Rome Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Rome Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Rome Therapeutics